LivaNova (LIVN) Stock Forecast & Price Target

Compare

273 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LIVN Analyst Ratings

Strong Buy

6 Buy

2 Hold

0 Sell

Based on 8 analysts giving stock ratings to

LivaNova

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LIVN Stock 12 Month Forecast

Average Price Target

$76.00

▲(35.96% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for LivaNova in the last 3 months. The average price target is $76.00 with a high forecast of $168.00 and a low forecast of $55.00. The average price target represents a 35.96% change from the last price of $55.90.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"$35","102":"$102","169":"$169","68.5":"$68.5","135.5":"$135.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":168,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$168.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$76.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$55.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,68.5,102,135.5,169],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.13,50.88923076923077,60.64846153846155,70.40769230769232,80.16692307692308,89.92615384615385,99.68538461538463,109.44461538461539,119.20384615384617,128.96307692307693,138.7223076923077,148.48153846153846,158.24076923076925,{"y":168,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.13,43.8123076923077,46.494615384615386,49.17692307692308,51.85923076923077,54.541538461538465,57.223846153846154,59.90615384615385,62.588461538461544,65.27076923076923,67.95307692307692,70.63538461538462,73.31769230769231,{"y":76,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.13,42.19692307692308,43.26384615384615,44.330769230769235,45.39769230769231,46.464615384615385,47.53153846153846,48.598461538461535,49.66538461538462,50.73230769230769,51.79923076923077,52.86615384615385,53.933076923076925,{"y":55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.32,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.6,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.29,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.31,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.95,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.63,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.03,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.79,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.41,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.13,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$168.00

Average Price Target$76.00

Lowest Price Target$55.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lila Implantra

TR | OpenAI - 4o

$55→$56

Hold

0.18%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

David Roman

Goldman Sachs

$162→$168

Buy

200.54%

Upside

Reiterated

08/08/25

LivaNova (LIVN) Receives a Buy from Goldman SachsGoldman Sachs analyst David Roman raised the price target on Livanova (NASDAQ: LIVN) to $168.00 (from $162.00) while maintaining a Buy rating.

Matthew Taylor

Jefferies

$79→$80

Buy

43.11%

Upside

Reiterated

08/07/25

Jefferies Sticks to Their Buy Rating for LivaNova (LIVN)

Anthony Petrone

Mizuho Securities

$55→$65

Buy

16.28%

Upside

Reiterated

08/07/25

Mizuho Securities Remains a Buy on LivaNova (LIVN)

David Rescott

Robert W. Baird

$55→$60

Buy

7.33%

Upside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Buy Rating on LivaNova (LIVN)

Rick Wise

Stifel Nicolaus

$60

Buy

7.33%

Upside

Reiterated

08/07/25

Stifel Nicolaus Remains a Buy on LivaNova (LIVN)

Michael Matson

Needham

$64

Buy

14.49%

Upside

Reiterated

08/06/25

LivaNova's Strong Financial Performance and Strategic Advancements Drive Buy Rating

Matt Miksic

Barclays

$55

Hold

-1.61%

Downside

Reiterated

06/05/25

Barclays Remains a Hold on LivaNova (LIVN)

Adam Maeder

Piper Sandler

$75

Buy

34.17%

Upside

Reiterated

05/22/25

LivaNova (LIVN) Receives a Buy from Piper Sandler

Michael Polark

Wolfe Research

$60

Buy

7.33%

Upside

Upgraded

05/19/25

Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lila Implantra

TR | OpenAI - 4o

$55→$56

Hold

0.18%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

David Roman

Goldman Sachs

$162→$168

Buy

200.54%

Upside

Reiterated

08/08/25

LivaNova (LIVN) Receives a Buy from Goldman SachsGoldman Sachs analyst David Roman raised the price target on Livanova (NASDAQ: LIVN) to $168.00 (from $162.00) while maintaining a Buy rating.

Matthew Taylor

Jefferies

$79→$80

Buy

43.11%

Upside

Reiterated

08/07/25

Jefferies Sticks to Their Buy Rating for LivaNova (LIVN)

Anthony Petrone

Mizuho Securities

$55→$65

Buy

16.28%

Upside

Reiterated

08/07/25

Mizuho Securities Remains a Buy on LivaNova (LIVN)

David Rescott

Robert W. Baird

$55→$60

Buy

7.33%

Upside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Buy Rating on LivaNova (LIVN)

Rick Wise

Stifel Nicolaus

$60

Buy

7.33%

Upside

Reiterated

08/07/25

Stifel Nicolaus Remains a Buy on LivaNova (LIVN)

Michael Matson

Needham

$64

Buy

14.49%

Upside

Reiterated

08/06/25

LivaNova's Strong Financial Performance and Strategic Advancements Drive Buy Rating

Matt Miksic

Barclays

$55

Hold

-1.61%

Downside

Reiterated

06/05/25

Barclays Remains a Hold on LivaNova (LIVN)

Adam Maeder

Piper Sandler

$75

Buy

34.17%

Upside

Reiterated

05/22/25

LivaNova (LIVN) Receives a Buy from Piper Sandler

Michael Polark

Wolfe Research

$60

Buy

7.33%

Upside

Upgraded

05/19/25

Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering LivaNova

1 Month

xxx

Success Rate

14/21 ratings generated profit

Average Return

+2.96%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.96% per trade.

3 Months

xxx

Success Rate

12/24 ratings generated profit

Average Return

-2.63%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -2.63% per trade.

1 Year

Michael MatsonNeedham

Success Rate

11/24 ratings generated profit

Average Return

-7.07%

reiterated a buy rating 18 days ago

Copying Michael Matson's trades and holding each position for 1 Year would result in 45.83% of your transactions generating a profit, with an average return of -7.07% per trade.

2 Years

xxx

Success Rate

14/29 ratings generated profit

Average Return

-7.67%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 48.28% of your transactions generating a profit, with an average return of -7.67% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LIVN Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LIVN has received 8 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. LIVN average Analyst price target in the past 3 months is 76.00.

Each month's total comprises the sum of three months' worth of ratings.

LIVN Financial Forecast

LIVN Earnings Forecast

Next quarter’s earnings estimate for LIVN is $0.92 with a range of $0.84 to $0.98. The previous quarter’s EPS was $1.05. LIVN beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.04% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.

LIVN Sales Forecast

Next quarter’s sales forecast for LIVN is $342.29M with a range of $337.10M to $345.89M. The previous quarter’s sales results were $352.52M. LIVN beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.24% of the time in the same period. In the last calendar year LIVN has Outperformed its overall industry.

LIVN Stock Forecast FAQ

What is LIVN’s average 12-month price target, according to analysts?

Based on analyst ratings, LivaNova PLC’s 12-month average price target is 76.00.

What is LIVN’s upside potential, based on the analysts’ average price target?

LivaNova PLC has 35.96% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LIVN a Buy, Sell or Hold?

LivaNova PLC has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.

What is LivaNova PLC’s price target?

The average price target for LivaNova PLC is 76.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $168.00 ,the lowest forecast is $55.00. The average price target represents 35.96% Increase from the current price of $55.9.

What do analysts say about LivaNova PLC?

LivaNova PLC’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of LIVN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

LivaNova (LIVN) Stock Forecast & Price Target

LIVN Analyst Ratings

LIVN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering LivaNova

LIVN Analyst Recommendation Trends

LIVN Financial Forecast

LIVN Earnings Forecast

LIVN Sales Forecast

LIVN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts